What Will USPTO-FDA Collaboration Look Like? Stakeholders To Weigh In On Proposed Initiatives

 
• By Brenda Sandburg

Agencies are holding public ‘listening session’ to get input on method of use patents and ‘skinny labeling,’ REMS patenting, PTAB proceedings and other topics.

FDA and USPTO
USPTO and FDA holding public meeting to get input on areas for collaboration • Source: Nielsen Hobbs; the Pink Sheet|Shutterstock images

More from Market Access

More from Pink Sheet